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Chronic obstructive pulmonary disease
AbstrAct
Introduction Hospital and emergency department 
discharge for patients with chronic obstructive pulmonary 
disease (COPD) is often poorly organised. We developed 
a patient-centred, evidence-based and consensus-
based discharge care bundle for patients with acute 
exacerbations of COPD.
Methods A purposeful sample of clinicians and patients 
were invited to participate in a two-round Delphi study 
(July–November 2015). In round 1, participants rated 
on a seven-point Likert scale (1=not at all important; 
7=extremely important) the importance of 29 unique 
COPD care actions. Round 2 comprised items selected 
from round 1 based on consensus (>80% endorsement 
for Likert values 5–7). A list of 18 care items from round 2 
was discussed in a face-to-face nominal group meeting.
results Seven care items were included in the COPD 
discharge bundle based on clinician and patient input: (1) 
ensure adequate inhaler technique is demonstrated; (2) 
send discharge summary to family physician and arrange 
follow-up; (3) optimise and reconcile prescription of 
respiratory medications; (4) provide a written discharge 
management plan and assess patient’s and caregiver’s 
comprehension of discharge instructions; (5) refer 
to pulmonary rehabilitation; (6) screen for frailty and 
comorbidities; and (7) assess smoking status, provide 
counselling and refer to smoking cessation programme.
conclusion We present a seven-item, patient-centred, 
evidence-based and consensus-based discharge bundle 
for patients with acute exacerbations of COPD. Alignment 
with clinical practice guidelines and feasibility of local 
adaptations of the bundle should be explored to facilitate 
wide applicability and evaluation of the effectiveness of the 
COPD discharge bundle. 
IntroductIon
Chronic obstructive pulmonary disease 
(COPD) is a common, chronic lung disease 
characterised by progressive and not fully 
reversible airflow limitation. Acute exacer-
bations of COPD are defined by worsening 
in patients’ baseline symptoms of dyspnoea, 
cough and sputum (quantity and puru-
lence); exacerbations become more frequent 
and severe as the disease progresses.1 These 
events constitute the single most important 
determinant of health status in patients with 
COPD2 and account for increased morbidity, 
frequent emergency department (ED) visits, 
hospitalisations and death.3 4 
A cornerstone of COPD management is 
preventing acute exacerbations of COPD 
and breaking the cycle of recurrence. A large 
body of evidence supports both pharmacolog-
ical and non-pharmacological interventions 
to reduce the risk of acute exacerbations of 
COPD and improve overall health status.5 
Despite this evidence, important care gaps 
remain as patients are often discharged 
from hospital or the ED following an acute 
exacerbation of COPD with no clear plan 
to prevent future episodes.6 Information 
exchange between hospital, ED and primary 
Key messages
 ► How is the consensus among expert clinicians and 
patients about the inclusion of individual care items 
into a discharge care bundle for patients with acute 
exacerbation of chronic obstructive pulmonary 
disease (COPD)?
 ► Seven evidence-based care items were included 
in a COPD discharge bundle based on clinician and 
patient input.
 ► This is the first use and reporting of a 
modified Delphi method to develop a COPD 
discharge care bundle informed by evidence, 
multidisciplinary clinical consensus and patients’ 
perspectives.
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care physicians about the acute exacerbation of COPD is 
often incomplete or unavailable at the first postdischarge 
outpatient appointment.7 Often, patients and families 
assume care coordination responsibilities and personally 
convey follow-up instructions to primary care physicians. 
Information is sometimes provided verbally, and patients 
often struggle with health literacy issues.8 9 This creates 
a critical situation in which inaccurate information is 
translated from acute to community care settings. There 
is a need to improve transitions of care for patients with 
COPD across ED, hospital and community settings and 
ensure coordination and continuity of care.10
Care bundles aim to meet these challenges and over-
come inconsistencies in clinical decision-making while 
supporting the translation of evidence to enhance COPD 
care. The Institute for Healthcare Improvement has 
defined care bundles as ‘a structured way of improving 
the processes of care and patient outcomes: a small, 
straightforward set of evidence-based practices that, when 
performed collectively and reliably, have been proven to 
improve patient outcomes’.11 A COPD discharge care 
bundle comprises a short list of evidence-based interven-
tions that should be implemented prior to discharge of 
all patients with acute exacerbations of COPD.12
A systematic review on the effectiveness of COPD 
discharge care bundles13 found moderate evidence that 
their implementation is likely to reduce readmissions 
after acute exacerbations of COPD. The review high-
lighted the importance of documenting the individual 
components of care bundles and understanding their 
interactions to influence patient outcomes. Ideally, the 
decision to include individual interventions in a COPD 
discharge bundle should be guided by best evidence, clin-
ical expertise and patient values.14 Despite the existence 
of clinical practice guidelines for COPD,1 4 15–18 there is no 
consensus about the core COPD care items that should 
be implemented at discharge to ensure a smooth transi-
tion to the community and reduce the risk of relapse.19 
This study describes the development of a discharge care 
bundle for patients with COPD that is based on evidence, 
consensus among clinical experts and patients’ feedback.
Methods
The study was conducted from July to November 2015 
and consisted of a two-round, modified Delphi survey plus 
one face-to-face nominal group meeting.20 The Delphi 
procedure is an explorative approach that uses a series 
of questionnaires to gather information about a topic of 
relevance to the participants in the study.21 It comprises 
distinct characteristics: anonymity, iteration, controlled 
feedback and statistical group response as expression of 
the degree of consensus.21 22 The aim of the process is to 
find consensus within a group of experts. In this study, 
patients were also regarded as experts for their individual 
experiences with accessing COPD care. 
A purposeful sample of 340 clinician experts was 
invited to participate. They were selected based on their 
clinical and research experience in the evaluation and 
treatment of patients with COPD. The study population 
included health providers involved in various aspects of 
COPD care (ie, hospital, emergency and primary care) 
in Alberta (Canada), and all members of the Canadian 
Thoracic Society (CTS) COPD Clinical Assembly. Names 
of Alberta clinician experts were obtained from websites 
of the College of Physicians and Surgeons of Alberta, 
the College and Association of Respiratory Therapists of 
Alberta, clinical departments at the University of Alberta 
and University of Calgary, and Alberta Health Services, 
which is the single health authority for the province. 
A convenience sample of 34 patients with COPD was 
recruited from two multidisciplinary respiratory clinics 
in Edmonton and Calgary (Alberta) using flyers distrib-
uted during their clinical appointments and by health 
providers’ referral. Since the aim was to recruit ‘repre-
sentative’ patients in terms of their experiences with 
COPD care at hospital discharge and not a representative 
overall sample, no exclusion criteria by COPD severity or 
demographic characteristics were applied.
Clinical experts were individually contacted by email, 
and patients were contacted in person. Each received a 
letter of consent describing the study and the expectations 
regarding their participation. A list of 29 unique COPD 
care actions occurring at either hospital or ED discharge 
was derived from a systematic review of the literature13 
and clinical practice guidelines,4 15–18 23 and included 
in the round 1 questionnaire. The questionnaires were 
pretested with a sample of two clinician experts and two 
patients not involved in subsequent Delphi rounds. The 
content of the patients’ questionnaires was adapted for a 
grade 6 level of reading to enhance comprehensiveness 
and acceptance.
Figure 1 describes the study flow. In round 1, partic-
ipants rated the importance of 29 unique COPD 
discharge care items on a seven-point Likert-type scale 
(1=extremely unimportant and 7=extremely important). 
In round 2, participants were presented with a list of 
COPD discharge items for which consensus was achieved 
in round 1 along with the group’s ratings. Participants 
were asked to reflect on the group responses and rate the 
importance of each COPD discharge item. For all Delphi 
rounds, consensus about the importance of individual 
COPD care items was defined a priori as at least 80% 
of endorsement for Likert values 5–7. Both first-round 
and second-round questionnaires for clinicians were 
distributed online via Research Electronic Data Capture 
(Vanderbilt University; Nashville, Tennessee, USA). The 
round 2 questionnaire was sent to all clinicians regardless 
of their participation in the first round. Non-respondents 
were sent two reminders at 2-week intervals after the 
initial distribution. Patients participating in round 1 were 
invited to complete the round 2 questionnaire at their 
next follow-up clinical visit. A face-to-face, nominal group 
meeting was convened in Edmonton on 16 November 
2015. The 44 participants included the CTS COPD 
Clinical Assembly, clinicians, researchers and health 
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administrators from Alberta with experience in COPD 
care. Results of Delphi rounds 1 and 2 were presented to 
meeting participants. They were invited to add new care 
items and review their wording prior to voting. Using a 
dot-counting method,24 participants selected individual 
care items for inclusion in the COPD discharge bundle 
based on the information gathered from the Delphi 
rounds, the systematic review,13 clinical expertise and 
patients’ feedback. The level of consensus for voting of 
individual COPD care items during the nominal group 
meeting was indicated by values above the median rank 
value.25
Descriptive statistics were used to report consensus. 
The level of agreement between clinicians and patients 
in Delphi round 1 was calculated using κ26 with 95% 
CIs, and classified as poor (κ<0.00), slight (k=0–0.20), 
fair (κ=0.21–0.40), moderate (κ=0.41–0.60), substantial 
(κ=0.61–0.80) and almost perfect (κ>0.80).27 Data from 
Likert scales were treated as categorical data and reported 
as proportions with percentages. Predictive Analysis Soft-
ware Statistics for Mac (PASWV.18.0, IBM SPSS, Somers, 
New York, USA) was used for all the analyses.
results
delphi participants
Of 340 potentially eligible clinicians that were 
approached via email, 70 (20.5%) completed the first 
Delphi round and 73 (21.4%) participated in round 
2. The expert panel that completed Delphi round 2 
(see table 1) included medical practitioners such as 
pulmonologists (27.1%), internists (14.3%), family/
general practitioners (11.4%), emergency physicians 
(7.1%), geriatricians (2.9%) and allied health providers 
including respiratory therapists (27.4%), physical ther-
apists (4.1%) and primary care nurses (2.7%). Clini-
cians were mostly based at academic hospitals (68.1%), 
specialty clinics (36.2%) and the ED (23.1%). The 
Figure 1 Flow diagram of Delphi procedures and study participants. COPD, chronic obstructive pulmonary disease.
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majority of them had between 16 and 30 years of experi-
ence within their disciplines (41.2%).
A total of 34 patients (table 2) completed the round 1 
questionnaire and 9 participated in round 2. Patients 
were mostly female (67.6%), older than 60 years of age 
(58.8%) and diagnosed with COPD in the last 10 years. 
Further, 70.6% of them had one or more admissions for 
acute exacerbation of COPD in the last year.
Delphi results
From 29 individual care items that were presented in 
round 1, clinicians selected 17 COPD care items, while 
patients endorsed 13 COPD care items (table 3). The 
level of agreement between clinicians and patients in the 
Table 1 Characteristics of clinician participants in Delphi 
study
Variable  n (%)
Sex 
  Male 36 (49.3)
  Female 35 (47.9)
  NR 2 (2.7)
Age (years) 
  <29 2 (2.7)
  30–39  16 (21.9)
  40–49  20 (27.4)
  50–59  24 (32.9)
  >60  9 (12.3)
  NR 2 (2.7)
Clinical discipline 
  Medical
   Pulmonologist 19 (27.1) *
   Internist 10 (14.3) *
   Family physician/general practitioner 8 (11.4)*
   Emergency physician 5 (7.1)*
   Geriatrician 2 (2.9)*
  Allied
   Respiratory therapist 20 (27.4)*
   Other (not specified) 10 (7.3) *
   Physical therapist 3 (4.1)*
   Primary care nurse 2 (2.7)*
Work setting 
  Acute care hospital 47 (68.1)*
  Specialty clinic 25 (36.2) *
  Emergency department 16 (23.1)*
  Primary care 11 (15.9)*
  Other 11 (15.9)*
Location of practice 
  Urban 55 (75.4)
  Semi-rural/rural 8 (10.9)
  NR 10 (13.7)
Years of practice 
  <15  26 (35.5)
  16–30  30 (41.2)
  >30  16 (21.9)
  NR 1 (1.4)
*Multiple responses were allowed.
NR, not reported.
Table 2 Characteristics of patient participants in Delphi 
study
Variable n (%)
Sex (n=34)
  Male  10 (29.4) 
  Female 23 (67.6)
  NR 1 (2.9)
Age (years) 
  40–49  3 (8.8)
  50–59  9 (26.5)
  ≥60  20 (58.8)
  NR 2 (5.9)
Place of residence 
  Urban 14 (41.2)
  Rural 12 (35.3)
  NR 8 (23.5)
Time since COPD diagnosis (years) 
  <2  4 (11.8)
  2– 5  8 (23.5)
  6– 10  9 (26.5)
  11– 15  4 (11.8)
  16– 20  3 (8.8)
  21– 25  2 (5.9)
  NR 4 (11.8)
COPD admissions last year 
  0 7 (20.6)
  1 9 (26.5)
  2–3 7 (20.6)
  ≥4 8 (23.5)
  NR 3 (8.8)
Living conditions 
  Live independent 15 (44.1)*
  Live with someone that can help with care 16 (47.1)*
  Live in rural area 7 (20.6)*
  Live in a small town 6 (17.6)*
  Live in city 19 (55.9)*
  Drive to appointments 15 (44.1)*
  Rely on others to go to appointments 7 (20.6)*
*Multiple responses were allowed.
COPD, chronic obstructive pulmonary disease; NR, not reported.
copyright.
 o
n
 15 January 2019 by guest. Protected by
http://bmjopenrespres.bmj.com/
BM
J O
pen Resp Res: first published as 10.1136/bmjresp-2017-000265 on 30 January 2018. Downloaded from 
Ospina MB, et al. BMJ Open Resp Res 2018;5:e000265. doi:10.1136/bmjresp-2017-000265 5
Open Access
round 1 selection of COPD items was moderate (κ=0.46; 
95% CI 0.15 to 0.76). There were some discrepancies 
between clinicians and patients in the prioritisation 
of COPD care items in round 1. The COPD care items 
endorsed by clinicians but not by patients were (1) assess 
smoking status and provide counselling, (2) refer to 
smoking cessation programme, (3) assess need for home 
care, (4) refer to pulmonary rehabilitation, (5) provide 
recommendations about influenza vaccination and (6) 
administer influenza vaccine. In contrast, two COPD care 
items were endorsed by patients but not by clinicians: (1) 
provide written education about COPD, a written action 
plan and ongoing case management, and (2) arrange 
follow-up appointment with a specialist.
In round 2, clinicians were presented with the 17 
COPD care items that were selected in round 1 and 
retained 15 of them. Patients in round 2 were presented 
with the 13 COPD care items selected from round 1, of 
which they retained 9 (table 4). There were discrep-
ancies between clinicians and patients in their round 2 
decisions: three COPD care items were endorsed by 
clinicians but not by patients: (1) ensure adequate 
Table 3 Delphi round 1 endorsement (%) of clinicians and patients on individual care items for inclusion in the chronic 
obstructive pulmonary disease (COPD) discharge bundle
Individual COPD care bundle items
Clinicians Patients
n (%) n (%)
1. Ensure adequate inhaler technique is demonstrated 71 (98.5) 33 (91)
2. Assess patient comprehension of discharge instructions 73 (97.2) 34 (97)
3. Assess need for oxygen therapy (short-term or long-term domiciliary oxygen) 73 (97.2) 33 (84.8)
4. Reconcile full range of respiratory medications 72 (95.9) 34 (88.2)
5. Arrange follow-up appointment with family physician. If patient does not have one, have 
him/her connected with one before discharge
73 (94.5)  3 (84.4)
6. Prescribe maintenance respiratory medications 72 (94.5) 33 (100)
7. Review full range of respiratory medications 72 (94.5) 34 (88.1)
8. Assess smoking status and provide counselling, as needed 72 (94.5) 34 (73.6)
9. Send discharge summary to family physician 71 (94.3) 34 (88.2)
10. Refer to smoking cessation programme, as needed 72 (91.7) 32 (78.1)
11. Assess need for home care 72 (91.7) 32 (65.6)
12. Refer to pulmonary rehabilitation, as needed 73 (90.5) 34 (79.4)
13. Provide recommendations about influenza vaccination 72 (90.3) 32 (75)
14. Provide recommendations about pneumococcal vaccination 72 (90.2) 32 (81.2)
15. Provide a written discharge action plan (a subacute plan of monitoring/management to 
prevent COPD relapse)
72 (86.1) 32 (81.3)
16. Administer pneumococcal vaccine, as needed 72 (84.8) 33 (81.9)
17. Administer influenza vaccine, as needed. 72 (83.3) 33 (75.8)
18. Provide a written COPD action plan (a chronic care plan of monitoring/management to 
prevent COPD relapse)
73 (78.1) 32 (78.1)
19. Provide written education about COPD + written  action plan + ongoing  case 
management
70 (75.7) 34 (82.4)
20. Assess need for occupational therapy referral 70 (75.7) 32 (78.2)
21. Arrange follow-up appointment with a respiratory nurse or certified respiratory educator 72 (75.1) 33 (69.7)
22. Assess need for social work referral 72 (72.2) 32 (56.3)
23. Provide written education about COPD + a  written action plan 73 (71.2) 34 (70.5)
24. Assess need for nutrition services referral 73 (71.2) 32 (71.9)
25. Follow-up phone calls after discharge 73 (67.1) 33 (66.6)
26. Arrange follow-up appointment with a specialist 72 (66.7) 33 (84.9)
27. Arrange for lung function testing after discharge 72 (66.7) 33 (69.7
28. Provide written education about COPD management 72 (66.7) 34 (73.6)
29. Perform spirometry at discharge 72 (54.2) 32 (62.5)
Endorsement≥80% indicated in bold. 
N, the total number of respondents per individual item. 
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inhaler technique is demonstrated, (2) arrange 
follow-up appointment with family physician and (3) 
assess need for oxygen therapy. Care items selected by 
patients but not by clinicians at the end of round 2 were 
the same as those in round 1.
nominal group meeting: participants and results
Participants in the nominal group meeting (n=44) were 
members of the CTS COPD Assembly (n=9), pulmonol-
ogists (n=8), researchers (n=7), health administrators 
(n=7), respiratory therapists (n=5), primary care physi-
cians (n=5), emergency physicians (n=2) and geriatri-
cians (n=1). They were presented with 18 care items 
selected either by clinicians or patients in Delphi round 
2 (n=18).
The nominal group meeting started with an interactive 
activity in which the content and wording of the 18 candi-
date care items were reviewed. Multiple statements were 
condensed into one care item, where possible. In this 
process, 12 original items were compressed into five state-
ments. These five abridged statements were reworded to 
make sure the meanings were unchanged. Two new care 
items that were not considered in Delphi rounds were 
added during the nominal group meeting: (1) screening 
for frailty and comorbid conditions, and (2) review goals 
of care. This process resulted in a final list of 13 COPD 
care items candidate for inclusion in the discharge bundle 
that were dot-counted during the nominal group meeting. 
Meeting participants voted on the 13 care items refined 
during the interactive activity. Each participant had a 
maximum of eight votes that she/he could use to select 
individual COPD care items for inclusion in the discharge 
care bundle. During an open discussion, meeting partici-
pants agreed on the cut-off mark for inclusion at 20 votes. 
The nominal group reached consensus on the inclu-
sion of seven unique care items in the COPD discharge 
bundle (figure 2): (1) ensure adequate inhaler technique 
is demonstrated; (2) send discharge summary to family 
physician and arrange follow-up; (3) optimise and recon-
cile prescription of respiratory medications; (4) provide a 
written discharge management plan and assess patients’ 
and caregivers’ comprehension of discharge instructions; 
(5) refer to pulmonary rehabilitation; (6) screen for 
frailty and comorbid conditions; and (7) assess smoking 
status, provide counselling and refer to smoking cessation 
programme.
Table 4 Delphi round 2 endorsement of clinicians and patients on individual care items for inclusion in the chronic 
obstructive pulmonary disease (COPD) discharge bundle
Individual COPD care bundle items
Clinicians Patients
 n (%)  n (%)
1. Ensure adequate inhaler technique is demonstrated 73 (98.6) 9 (77.7)
2. Send discharge summary to family physician 73 (98.6) 9 (88.9)
3. Reconcile full range of respiratory medications 73 (98.6) 9 (100)
4. Assess patient comprehension of discharge instructions 73 (97.3) 9 (100)
5. Review full range of respiratory medications 72 (97.2) 9 (100)
6. Arrange follow-up appointment with family physician. If patient does not have one, have 
him/her connected with one before discharge
73 (95.8) 9 (66.6)
7. Prescribe maintenance respiratory medications 72 (94.5) 8 (88.9)
8. Assess need for oxygen therapy (short-term or long-term domiciliary oxygen) 72 (94.4) 9 (77.8)
9. Assess smoking status and provide counselling, as needed 73 (91.7) ns
10. Assess need for home care 71 (91.6) ns
11. Refer to smoking cessation programme, as needed 71 (88.7) ns
12. Refer to pulmonary rehabilitation, as needed 72 (86.2) ns
13. Provide recommendations about influenza vaccination 72 (84.7) ns
14. Provide recommendations about pneumococcal vaccination 73 (82.2) 9 (88.8)
15. Provide a written discharge action plan (a subacute plan of monitoring/management to 
prevent COPD relapse)
72 (80.5) 9 (88.8)
16. Administer influenza vaccine, as needed 73 (78) ns
17. Administer pneumococcal vaccine, as needed 71 (71.8) 9 (66.6)
18. Arrange follow-up appointment with a specialist ns 9 (88.9)
19. Provide written education about COPD + written  action plan + ongoing  case 
management
nsns 9 (88.8)
Endorsement≥80% indicated in bold.
N, the total number of respondents per individual item; ns,  not selected for round 2. 
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dIscussIon
To our knowledge, this is the first reporting of a modi-
fied Delphi method to develop a COPD discharge care 
bundle informed by evidence, multidisciplinary clinical 
consensus and patients’ perspectives. Using a mixed-
methods approach we developed a seven-item patient-cen-
tred, evidence-based and consensus-based discharge 
bundle for patients with acute exacerbations of COPD.
There are important variations in the number and 
content of individual components of COPD discharge 
bundles published in scientific studies.13 Our discharge 
bundle incorporated seven care items, a number that is 
aligned with recommendations about the optimal number 
of individual items for inclusion in care bundles.11 Others 
have included between 2 and 12 individual interventions, 
with a median number of 5 care items per bundle.13 
Some care items in the COPD discharge bundle have 
been part of other published bundles. For example, care 
item #1 was part of COPD discharge bundles in 9 out of 
14 studies included in the Ospina et al systematic review.13 
Care items #2, #4 and #5 were included in bundles of 
eight studies, and care item #7 was included in seven 
studies evaluating other bundles. Care items #3 (three 
studies) and #6 (none) were less frequently included in 
other bundles. In contrast, educational programmes on 
self-management (included in nine studies) were not 
selected for the COPD discharge bundle.
This study is one of the few initiatives to inform the 
selection of individual components of COPD discharge 
bundles. The majority of studies in the field have not 
explained how individual care items were generated or 
selected for inclusion.13 19 This lack of detail limits the 
ability of readers to understand how these bundles work, 
how they incorporate the best available evidence and 
whether individual components are accepted by patients 
and clinicians.
Care bundles were originally developed to improve 
adherence to clinical practice guidelines28 and to decrease 
variations in care29; however, consistent uptake of recom-
mendations from clinical practice guidelines into care 
bundles remains challenging.28 For example, in North 
America, the American College of Chest Physicians 
(CHEST) and the CTS have developed recommendations 
about both pharmacological and non-pharmacological 
treatments to prevent acute exacerbations of COPD (the 
Acute Exacerbations of Chronic Obstructive Pulmonary 
Disease (AECOPD) Guidelines).4 Not all AECOPD Guide-
line recommendations were translated into individual 
items in the COPD discharge bundle. Of 10 non-pharma-
cological recommendations in the AECOPD Guidelines,4 3 
(ie, refer to pulmonary rehabilitation, having a written plan 
and case management for the prevention of acute exac-
erbations of COPD and smoking cessation counselling) 
were included in the COPD discharge bundle. Others (ie, 
administration of pneumococcal and influenza vaccines) 
were not included. One potential explanation for this lack 
of agreement is that the AECOPD Guidelines were based 
on a critical appraisal of the evidence supporting individual 
actions for preventing acute exacerbations of COPD,4 
whereas selection of care items in the COPD discharge 
bundle was based on evidence supporting bundles as a 
sum of individual components, plus clinician consensus 
and patients’ perspectives on their relative importance. 
Alignment with clinical practice guidelines and feasibility 
of local adaptations of the COPD discharge bundle should 
be further explored to ensure wide applicability.
Figure 2 Results of the nominal group voting on the inclusion of individual care items in the chronic obstructive pulmonary 
disease (COPD) discharge bundle.
copyright.
 o
n
 15 January 2019 by guest. Protected by
http://bmjopenrespres.bmj.com/
BM
J O
pen Resp Res: first published as 10.1136/bmjresp-2017-000265 on 30 January 2018. Downloaded from 
8 Ospina MB, et al. BMJ Open Resp Res 2018;5:e000265. doi:10.1136/bmjresp-2017-000265
Open Access
strengths and limitations
The Delphi procedure is a valid method to determining 
consensus for clinical improvement practices in health-
care settings.30 The number of experts (both clinicians 
and patients) who participated in both the Delphi and 
nominal group phases of the study surpassed the sample 
size recommended for content validation (ie, 5–10 
experts)31 of the COPD discharge care bundle. They 
represent multidisciplinary professional groups that 
directly influence patient care and the development of 
clinical practice guidelines. An important strength of this 
study was the participation of the CTS COPD Assembly 
and different types of clinicians, including primary care 
physicians who are instrumental in the integration of acute 
and chronic care of patients with COPD after discharge. 
This is key from a knowledge translation perspective. 
Also, incorporating the perspectives of patients with 
COPD is an important strength in the development of 
a patient-centred bundle that is more likely to lead to 
treatment adherence and better outcomes.32 Lastly, the 
COPD care bundle represents a balance between prag-
matism and completeness. The total number of items is 
not evidence-based, but the seven items identified in this 
study represent a consensus of what is possible, feasible 
and valid in practice.
This study has some limitations. Because clinician 
and patient samples were selected using non-random 
procedures (ie, purposeful and convenience sampling, 
respectively), representativeness, in a statistical sense, 
was not assured. Clinicians were predominantly experts 
from large, urban, academic hospitals, thereby limiting 
generalisation of results to rural, non-academic settings. 
The importance given to individual care items may 
vary according to local criteria and their availability in 
the settings from which the clinicians practice. Simi-
larly, patients in the Delphi study may not fully repre-
sent those with very severe COPD that are more likely 
to have frequent admissions for acute exacerbations of 
COPD and require implementation of the discharge care 
bundle more often.
This Delphi study was conducted in Canada, a country 
with a publicly funded universal healthcare system. The 
selection of individual care items for a COPD discharge 
care bundle in countries with other health insurance 
models may differ as financial and insurance barriers 
often impede access to some individual COPD care items 
considered such as access to pulmonary rehabilitation 
services and appropriate inhaler medication. Therefore, 
generalisability of the COPD discharge bundle to other 
health systems may be limited. Local adaptations of the 
bundle should be evaluated prior to implementation in 
health systems supported by other financial and insur-
ance arrangements. Adjustments in the content of COPD 
discharge bundles can be guided by consideration of 
system-level failures and unmet patient needs.33
An aspect that should be explored in future studies is 
whether individual components are perceived as more 
important for bundle effectiveness than the sum of all 
components. Some may argue that the strength of a 
COPD discharge bundle is that all individual interven-
tions should be implemented in every eligible patient 
with COPD under a ‘all-or-none’ approach.34 Others 
have questioned whether a ‘one-size-fits-all’ model is 
appropriate for discharge bundles that are meant to be 
implemented for the spectrum of patients with COPD 
and the diverse settings where they receive care.19
The work presented here is the second step of a multi-
stage process aimed at evaluating the implementation 
and effectiveness of an evidence-based, patient-oriented 
discharge care bundle for patients with COPD. The first 
step was a systematic review of the scientific literature13 
that provided the evidence base for the discharge bundle 
development. Since the completion of the Delphi study, 
the research team engaged in the design and planning 
of a multicentre trial (www. clinicaltrials. gov; study ID: 
NCT03358771) to evaluate the implementation and 
effectiveness of the COPD discharge bundle. Enrolment 
in the trial is expected to conclude in 2019, with the goal 
to obtain sufficient data for reliable estimates of the treat-
ment effect for clinical decision-making.
conclusIons
This study proposes a patient-centred, evidence-based 
and consensus-based discharge care bundle for patients 
with acute exacerbations of COPD. The goal is that the 
discharge care bundle will ensure that patients with 
COPD are managed appropriately, effectively and in 
ways that are acceptable for them. This COPD discharge 
bundle provides a foundation for further research and 
critical evaluation of barriers and facilitators for imple-
mentation, implementation fidelity and effectiveness in 
healthcare settings.
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